Latest News
Health Canada grants approval to Merck's KEYTRUDA for first-line treatment of gastric cancer
19 April 2024 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Friday Health Canada's approval of KEYTRUDA (pembrolizumab) in combination with chemotherapy for adult patients with ad...
YS Biopharma's YS-HBV-002 receives Philippine clinical trial approval
19 April 2024 - YS Biopharma Co., Ltd. (Nasdaq: YS), a China-based global biopharmaceutical company, announced on Thursday that it has received clinical trial approval from the Philippine Food and Drug Administration (PFDA) for its YS-HBV-002 immunot...
GIE Medical commences patient enrolment for Chronic Benign Stricture - Bowel (PATENT-B) study
19 April 2024 - GIE Medical, a US-based, clinical stage company, announced on Thursday that it has enrolled the first patient for its Paclitaxel Coated Balloon for the treatment of Chronic Benign Stricture - Bowel (PATENT-B) study.The study is evalua...
Initial Therapeutics names new president, chief executive officer and board member
19 April 2024 - Initial Therapeutics Inc., a California-based life sciences company, announced on Thursday that it has named Peter DiLaura as its new president, chief executive officer and member of the company's board of directors, effective im...
Anixa Biosciences adds Dr Sanjay Juneja to Cancer Business Advisory Board
19 April 2024 - Anixa Biosciences, Inc. (NASDAQ: ANIX), a California-based clinical-stage biotechnology company, announced on Thursday that it has added Sanjay Juneja, MD to its Cancer Business Advisory Board.Dr Juneja, a board-certified haematologis...